0001950047-23-000497.txt : 20230510 0001950047-23-000497.hdr.sgml : 20230510 20230510152330 ACCESSION NUMBER: 0001950047-23-000497 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230510 DATE AS OF CHANGE: 20230510 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 23905925 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Smith Brendan CENTRAL INDEX KEY: 0001857492 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 144 1 primary_doc.xml 144 0001857492 XXXXXXXX LIVE 0001674416 CRISPR THERAPEUTICS AG 001-37923 Baarerstrasse 14 Zug V8 6300 41 (0)41 561 32 77 Brendan Smith Officer Common Morgan Stanley Smith Barney LLC

1 New York Plaza 38th Floor New York NY 10004

9583 662402.83 78935098 05/10/2023 NASD Common 05/10/2023 Stock Option Exercise Issuer N 9583 05/10/2023 Cash Y 05/10/2023 /s/ Brendan Smith